Exploring Case 2 Relapsed Cml With T315i Mutation
Let's dive into the details surrounding Case 2 Relapsed Cml With T315i Mutation.
- This video is part of the HMP Education content archive and may include previously accredited educational material. While this ...
- Naval Daver, MD; Kendra Sweet, MD; and Javier Pinilla-Ibarz, MD, PhD, discuss the treatment of patients with
- Giuseppe Saglio, MD, University of Turin, Turin, Italy, emphasizes the importance of better understanding
- Fabian Lang, MD, Goethe University, Frankfurt, Germany, gives an overview of the results of a Phase I trial evaluating the safety ...
- Javier A. Pinilla-Ibarz, MD, PhD, reviews the
In-Depth Information on Case 2 Relapsed Cml With T315i Mutation
The role of molecular testing and biopsy in the assessment of a patient with Javier A. Pinilla-Ibarz, MD, PhD, comments on how to characterize the 64-year-old patient's response to imatinib, the importance ... This video is part of the HMP Education content archive and may include previously accredited educational material. While this ... Nicholas Short, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, discusses the challenges in treating ...
Michael J. Mauro, MD, provides insight on the importance of
That wraps up our extensive overview of Case 2 Relapsed Cml With T315i Mutation.